Finance

Lists
TGTX:NASDAQ
TG Therapeutics Inc common stock
52,95 $
+1,46%
(+0,76) 1D
52,90 $
-0,09% (-0,050)
After hours
Closed: 7 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TGTX...
Open
51,83 $
High
53,88 $
Low
51,40 $
Mkt. cap
8,11 млрд
Avg. vol.
1,79 млн
Volume
1,51 млн
P/E ratio
19,29
52-wk high
59,30 $
52-wk low
26,76 $
EPS
2,75 $
Beta
1,80
Shares outstanding
153,07 млн
No. of employees
399
Open
51,83 $
High
53,88 $
Low
51,40 $
Mkt. cap
8,11 млрд
Avg. vol.
1,79 млн
Volume
1,51 млн
P/E ratio
19,29
52-wk high
59,30 $
52-wk low
26,76 $
EPS
2,75 $
Beta
1,80
Shares outstanding
153,07 млн
No. of employees
399
News stories
From web sources and news partners
About TG Therapeutics Inc common stock
CEOMichael S Weiss
Employees399
Founded1993
HeadquartersMorrisville, Солтүстік Каролина, Америка Құрама Штаттары
Sector-
Analyst ratings
Based on 6 analysts giving stock ratings to TGTX in the past 3 months
Buy
Buy
5
Hold
0
Sell
1
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for TGTX in the last 3 months.
Highest
Current 52,95 $
86,00 $ (+62,42%)
Average
69,17 $ (+30,63%)
Lowest
21,00 $ (-60,34%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Maintained
78,00 $
+47,3%
09/21/2026
William Wood
B. Riley Securities
Buy
Maintained
86,00 $
+62,4%
09/02/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
86,00 $
+62,4%
09/02/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
72,00 $
+36%
08/10/2026
Alec Stranahan
Bank of America Securities
Sell
Reiterated
21,00 $
-60,3%
08/05/2026
Tara Bancroft
TD Cowen
Buy
Maintained
75,00 $
+41,6%
08/03/2026
Roger Song
Jefferies
Buy
Maintained
83,00 $
+56,8%
07/14/2026
Unknown Analyst
Jefferies
Buy
Maintained
83,00 $
+56,8%
06/22/2026
Unknown Analyst
B. Riley Securities
Buy
Reiterated
55,00 $
+3,9%
06/03/2026
Corinne Johnson
Goldman Sachs
Hold
Maintained
41,00 $
-22,6%
06/03/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
161,71 млн
192,57 млн
204,92 млн
240,34 млн
Cost of goods sold
28,09 млн
38,14 млн
33,51 млн
41,19 млн
Cost of revenue
28,09 млн
38,14 млн
33,51 млн
41,19 млн
Research and development expenses
40,88 млн
41,19 млн
48,40 млн
95,34 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
63,37 млн
62,74 млн
88,22 млн
82,13 млн
Operating expense
104,25 млн
103,94 млн
136,61 млн
177,47 млн
Total operating expenses
132,34 млн
142,08 млн
170,12 млн
218,66 млн
Operating income
29,36 млн
50,49 млн
34,80 млн
21,67 млн
Other non operating income
3,26 млн
1,13 млн
2,39 млн
5,13 млн
EBT including unusual items
25,91 млн
45,09 млн
20,36 млн
10,23 млн
EBT excluding unusual items
25,91 млн
45,09 млн
29,52 млн
10,23 млн
Income tax expense
-364,99 млн
22,06 млн
586,00 м.
2,45 млн
Effective tax rate
-1 408,72%
48,91%
2,88%
23,97%
Other operating expenses
-
-
-
-
Net income
390,90 млн
23,04 млн
19,78 млн
7,78 млн
Net profit margin
241,73%
11,96%
9,65%
3,24%
Earnings per share
0,16
0,14
0,18
0,05
Interest and investment income
-
-
-
-
Interest expense
-6,72 млн
-6,53 млн
-7,67 млн
-16,57 млн
Net interest expenses
-6,72 млн
-6,53 млн
-7,67 млн
-16,57 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
29,38 млн
50,52 млн
34,83 млн
21,73 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары